Skip to main content
iBio, Inc. (IBIO)
NYSEAMERICAN: IBIO · Real-Time Price · USD
2.480
+0.060 (2.48%)
At close: Dec 20, 2024, 4:00 PM
2.310
-0.170 (-6.85%)
After-hours: Dec 20, 2024, 7:58 PM EST

iBio, Inc. Revenue

iBio, Inc. had revenue of $175.00K in the twelve months ending September 30, 2024, up 250.00% year-over-year. In the fiscal year ending June 30, 2024, iBio, Inc. had annual revenue of $225.00K.

Revenue (ttm)
$175.00K
Revenue Growth
+250.00%
P/S Ratio
80.63
Revenue / Employee
$10,938
Employees
16
Market Cap
22.69M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 2024225.00K--
Jun 30, 2023---
Jun 30, 20221.88M-487.00K-20.54%
Jun 30, 20212.37M733.00K44.75%
Jun 30, 20201.64M-380.00K-18.83%
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Jun 30, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Allurion Technologies 34.75M
Vivos Therapeutics 14.58M
Pulmatrix 10.01M
Co-Diagnostics 7.32M
NeuroOne Medical Technologies 3.45M
GeoVax Labs 3.09M
NeurAxis 2.46M
Revenue Rankings

IBIO News

More News